Clinical Trial Update: Combination Therapy of F8IL10 and Methotrexate in Rheumatoid Arthritis Patients [Phase 1]

View source ↗

Summary

A Phase 1 trial assessing the safety and tolerability of combining F8IL10 with methotrexate in rheumatoid arthritis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• F8IL10
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Philogen S.p.A. | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED